Comparison of Ultrasound-Guided Infraclavicular Block and Ultrasound-Guided Axillary Block
NCT ID: NCT01761175
Last Updated: 2017-08-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
224 participants
INTERVENTIONAL
2012-09-30
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
US Guided Axillary Block With Only One Injection
NCT02334176
Comparison of Two Different Ultrasound Guided Techniques for Saphenous Nerve Block
NCT02383615
Efficacy of Ultrasound-guided Axillary Nerve Block Versus Ultrasound-guided Peripheral Forearm Block in Patients Undergoing Hand Surgery
NCT04678765
Ultrasound-guided Selective Shoulder Block Versus Ultrasound-guided Interscalene Brachial Plexus Block, an RCT
NCT02415088
Suprascapular and Axillary Blocks Versus Interscalene Block for Shoulder Surgery
NCT02517437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultrasound-guided infraclavicular block
Ultrasound-guided single injection infraclavicular block
Ultrasound-guided infraclavicular block
Ultrasound-guided single injection infraclavicular block: using an in-plane technique, 30 mL of mepivacaine 1.5% is injected at the posterior aspect of the artery.
Ultrasound-guided axillary block
Ultrasound-guided double injection axillary block
Ultrasound-guided axillary block
Ultrasound-guided double injection axillary block: using an in-plane technique, 25 mL of mepivacaine 1.5% is injected postero-medial to the artery. During needle withdrawal, 5 mL of the same solution is injected close to the musculocutaneous nerve.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound-guided infraclavicular block
Ultrasound-guided single injection infraclavicular block: using an in-plane technique, 30 mL of mepivacaine 1.5% is injected at the posterior aspect of the artery.
Ultrasound-guided axillary block
Ultrasound-guided double injection axillary block: using an in-plane technique, 25 mL of mepivacaine 1.5% is injected postero-medial to the artery. During needle withdrawal, 5 mL of the same solution is injected close to the musculocutaneous nerve.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists Class 1 to 3
* Undergoing a surgery at the elbow, forearm, wrist or hand under regional anesthesia
Exclusion Criteria
* Body mass index more than 40 kg/m2
* Weight less than 45 kg
* Patient refusal
* Contraindication to regional anesthesia (coagulopathy, local infection at the puncture site, systemic infection)
* Previous neurological deficit in the operated arm
* Severe renal or hepatic failure
* Prior surgery in the axillary or infraclavicular area
* Pregnancy or breast-feeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHU de Quebec-Universite Laval
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ariane Boivin
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ariane Boivin, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Québec
Marie-Josée Nadeau, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Québec
Nicolas Dion, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Québec
Simon Lévesque, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Québec
Pierre C. Nicole, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Québec
Alexis F. Turgeon, MD, Msc
Role: PRINCIPAL_INVESTIGATOR
CHU de Québec
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital de l'Enfant-Jésus
Québec, , Canada
Hôpital de Saint-Sacrement
Québec, , Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Boivin A, Nadeau MJ, Dion N, Levesque S, Nicole PC, Turgeon AF. Ultrasound-Guided Single-Injection Infraclavicular Block Versus Ultrasound-Guided Double-Injection Axillary Block: A Noninferiority Randomized Controlled Trial. Anesth Analg. 2016 Jan;122(1):273-8. doi: 10.1213/ANE.0000000000001017.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEJ-666
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.